A 58-year-old man with hypertension and benign prostatic hyperplasia (BPH) presents to the clinic. His current medications include lisinopril and finasteride. He complains of persistent urinary hesitancy and weak stream despite 6 months of finasteride therapy. On examination, his blood pressure is 148/92 mmHg. The urologist recommends adding an alpha-1 adrenergic antagonist. Which of the following agents would be the MOST selective for alpha-1A receptors in the prostate, thereby minimizing vasodilation and hypotension?

Explanation

## Receptor Selectivity and Clinical Pharmacology **Key Point:** Alpha-1 adrenergic receptors exist as three subtypes (α1A, α1B, α1D), with distinct tissue distribution and functional consequences. α1A receptors predominate in the prostate and bladder neck, while α1B receptors mediate vascular smooth muscle contraction. ### Alpha-1 Antagonist Selectivity Profile | Agent | α1A Selectivity | α1B Selectivity | Vascular Effects | Urinary Symptoms | Clinical Use | |-------|-----------------|-----------------|------------------|------------------|---------------| | **Tamsulosin** | ✓✓✓ High (10-fold) | ✓ Low | Minimal hypotension | Excellent | BPH (first-line) | | **Doxazosin** | ✓ Moderate | ✓✓ High | Significant | Good | BPH + HTN | | **Prazosin** | ✓ Moderate | ✓✓ High | Significant | Good | HTN (rarely BPH) | | **Phentolamine** | Non-selective | Non-selective | Severe hypotension | N/A | Pheochromocytoma only | **High-Yield:** Tamsulosin is the only uroselective alpha-1A antagonist approved for BPH monotherapy. Its 10-fold selectivity for α1A over α1B receptors explains why it causes minimal blood pressure reduction compared to non-selective agents like doxazosin. ### Mechanism of Selectivity Tamsulosin's chemical structure (sulfonamide moiety) confers conformational selectivity for the α1A receptor isoform. This selectivity is **tissue-based** rather than organ-based: - **Prostate/bladder neck:** α1A-mediated relaxation → improved flow - **Vasculature:** α1B-mediated contraction → preserved vascular tone **Clinical Pearl:** In this patient with hypertension and BPH, tamsulosin is preferred because: 1. It treats BPH symptoms effectively (weak stream, hesitancy) 2. It does NOT worsen hypertension (unlike doxazosin, which would lower BP further) 3. First-dose syncope is rare with tamsulosin (unlike prazosin) **Warning:** Doxazosin, while effective for both BPH and hypertension, is non-selective and causes vasodilation. In a hypertensive patient already on lisinopril, adding doxazosin risks excessive hypotension and orthostatic symptoms. ### Why Tamsulosin Over Alternatives 1. **Doxazosin** — Non-selective; would lower BP excessively in this hypertensive patient 2. **Prazosin** — Non-selective; high first-dose syncope risk; rarely used for BPH 3. **Phentolamine** — Irreversible, non-selective antagonist; used only for acute pheochromocytoma crisis, not chronic BPH [cite:KD Tripathi 8e Ch 10]